Modifying the requirements for drug take-back programs.

Jurisdiction:: Washington
Type:: EPR
Last action:: May 3, 2021

Pharmaceuticals

HB-1161 modifies drug take-back program requirements, which constitutes Extended Producer Responsibility for pharmaceutical products by establishing producer-funded collection and disposal infrastructure.

View on LegiScan ↗

The original source link is unavailable — showing the bill on LegiScan instead.

Explore more circular-economy legislation on the Atlas Circular legislation tracker.